ADCYAP1 and anxiety disorder: The available data strongly suggest that at any applications of PACAP treatments, the duration and concentrations of PACAP agents must be carefully considered to avoid unwanted consequences such as a migraine-attack, anxiety disorder, or even tumor formation.